Cryo-EM has transformed structural biology by enabling atomic-resolution imaging of macromolecules without requiring crystallization. The method involves flash-freezing samples in vitreous ice and visualizing them… Read More »Structural Biology Research May Take a Hit Amid Fiscal Uncertainty
CEMS have long served as the workhorse of industrial environmental compliance. These systems are designed to measure, record, and report atmospheric emissions in real time,… Read More »PAI Market Profile: Continuous Emissions Monitoring Systems (CEMS)
In the intricate ecosystem of scientific research, few issues provoke as much quiet upheaval as the distinction between direct and indirect costs. These two pillars… Read More »Indirect Cost Caps Are Reshaping Scientific Research
In 2025, the scientific research community is grappling with a perfect storm of financial and operational challenges. Analytical instrument purchases, once predictable line items in… Read More »Turbulent R&D Funding Climate Kneecapping Research and Capital Equipment Purchases
While the analytical rigor of HPLC systems remains foundational, the demands placed on service delivery have evolved. Today’s laboratories require more than reliable instruments; they… Read More »The Future of HPLC Support Is Integration Intelligence and Impact
The US analytical instruments industry has experienced a dramatic evolution in its trade balance over the past five years. What once was a period of… Read More »From Expansion to Uncertainty: The Evolving Trade Landscape for US Analytical Instruments
Data centers are among the most energy-intensive facilities in the world, with power demands varying based on size and workload. A small data center (5,000–20,000… Read More »Data Centers Fuel Demand for Process Gas Analyzers
The International Monetary Fund (IMF) released its April 2025 World Economic Outlook (WEO): A Critical Juncture amid Policy Shifts, soon after the US announced its latest round of tariffs—to be implemented nearly universally. The US began instituting new tariffs in February, and, although some trading partners responded with countermeasures, market responses were not particularly notable. However, with the April 2 announcement, tariff rates rose to the highest levels in about a century—a negative growth shock. Major equity indices experienced historic drops followed by a partial recovery after April 9, when a pause and some adjustments were announced. The unpredictable nature of these tariffs has had a negative impact on economic activity, and uncertainty, especially regarding trade policy, has soared.
Recent gradual improvements in the life science and analytical instrument markets continued in the fourth quarter of 2024.
Artificial intelligence, energy challenges, climate change and new blockbuster drugs (e.g., GLP-1) are key drivers for the lab and process market. However, the uncertainty of policies of newly elected administrations favoring deglobalization and deregulation have the potential to cause disruption, both in the analytical instruments industry and macroeconomically. As a result, our outlook for 2025 is